Aspen Aerogels Inc (NYSE:ASPN) has a beta value of 2.21 and has seen 1.65 million shares traded in the last trading session. The company, currently valued at $1.49B, closed the last trade at $18.05 per share which meant it gained $0.21 on the day or 1.18% during that session. The ASPN stock price is -83.66% off its 52-week high price of $33.15 and 58.61% above the 52-week low of $7.47. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.9 million shares traded. The 3-month trading volume is 2.28 million shares.
The consensus among analysts is that Aspen Aerogels Inc (ASPN) is Buy stock at the moment, with a recommendation rating of 1.09. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 10 have rated it as a Hold, with 9 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.08.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aspen Aerogels Inc (NYSE:ASPN) trade information
Sporting 1.18% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ASPN stock price touched $18.05 or saw a rise of 10.6%. Year-to-date, Aspen Aerogels Inc shares have moved 14.39%, while the 5-day performance has seen it change -5.00%. Over the past 30 days, the shares of Aspen Aerogels Inc (NYSE:ASPN) have changed -25.29%. Short interest in the company has seen 8.52 million shares shorted with days to cover at 4.06.
Wall Street analysts have a consensus price target for the stock at $32, which means that the shares’ value could jump 43.59% from current levels. The projected low price target is $18.0 while the price target rests at a high of $38.0. In that case, then, we find that the current price level is -110.53% off the targeted high while a plunge would see the stock lose 0.28% from current levels.
Aspen Aerogels Inc (ASPN) estimates and forecasts
Figures show that Aspen Aerogels Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -28.12% over the past 6 months, with this year growth rate of 115.15%, compared to 6.10% for the industry. Revenue growth from the last financial year stood is estimated to be 74.20%.
11 analysts offering their estimates for the company have set an average revenue estimate of 109.36M for the current quarter. 11 have an estimated revenue figure of 94.05M for the next ending quarter. Year-ago sales stood 51.84M and 84.22M respectively for this quarter and the next, and analysts expect sales will grow by 111.00% for the current quarter and 74.20% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 14.58% over the past 5 years.
ASPN Dividends
Aspen Aerogels Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aspen Aerogels Inc (NYSE:ASPN)’s Major holders
Insiders own 16.61% of the company shares, while shares held by institutions stand at 75.95% with a share float percentage of 91.08%. Investors are also buoyed by the number of investors in a company, with Aspen Aerogels Inc having a total of 316.0 institutions that hold shares in the company. The top two institutional holders are KIM, LLC with over 12.28 million shares worth more than $292.89 million. As of 2024-06-30, KIM, LLC held 16.209% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 4.49 million shares as of 2024-06-30. The firm’s total holdings are worth over $107.14 million and represent 5.9295% of shares outstanding.
